The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
In Cardiology Patients, there's Old, Older, and Oldest, and that Distinction Matters
Despite demographic shifts that are steadily increasing how long people are living,most medical research lumps everyone over 65 (or even over 60) into the same group. That's about to change, say's NYU's John A. Dodson, MD, MPH.
A retrospective analysis of transesophageal echocardiography from 388 patients undergoing catheter ablation for atrial fibrillation has found no significant evidence that novel oral anticoagulants reduce the incidence of left atrial thrombus or eliminate the need for transesophageal echocardiography before ablation.
Kathleen Hickey From Columbia University: Stroke Prevention and the Role of Anticoagulants
Anticoagulants have been used for many years in the medical community, and now with the development of new agents patients can see better results without the risk of as many adverse events.
Kathleen Hickey From Columbia University: Helping Patients Manage Atrial Fibrillation
For patients diagnosed with atrial fibrillation the prospects of treatment can be scary and intimidating. With a team based approach that care can help them live normal lives while safely managing their condition.
Genomic Scoring Useful in Treating Systolic Heart Failure
In systolic heart failure, a fixed dose combinatin of isosorbide dinitrate and hydralazine is more effective in black patients. Building on that information, researchers in Pittsburgh looked at ways to use a genomic score to predict which patients would benefit most.
What Are We Waiting for? Khurram Nasir, MD on Using Mammograms to Find Heart Risk
Microcalcifications that can show up on mammograms can also predict a woman's risk of heart disease. MD Magazine spoke to Khurram Nasir, MD, co-author of an editorial urging physicians and their specialty societies to put this finding into practice.
Analysis of cardiovascular registry data comparing components of the CHA2DS2-VASc score and oral anticoagulant use also found that women and patients with vascular disease were less likely than other patients with atrial fibrillation to be prescribed anticoagulation that is now indicated by standard guidelines.
With the announcement of a new medical school thanks to a partnership between Seton Hall University and Hackensack University Health Network the two New Jersey institutions are working to address a growing shortage of physicians in a number of specialties across the country.
Hackensack University Medical Center can trace its roots back to a blizzard back in the late 1800's when residents in northern New Jersey could not get across the Hudson River to get the care they needed. Since that time it has grown into the flagship of one of the largest health networks in the metropolitan area.